The Allstate Corporation · ALL · FY2024 Q4 · Calendar Q1 2025
Allstate: Strong Q4 underwriting, growth plans face catastrophe and retention risks
The supplied analysis supports a cautiously constructive view of Allstate's operating trajectory: stronger underwriting and product expansion provide growth support, while catastrophe losses, retention pressure, and execution around capital redeployment could limit the durability of that progress.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about ALL FY2024 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter, the supplied analysis shows a shift from pending initiatives to a stronger Q4 operating update: affordable simple connected auto was available in 31 states, underwriting margins improved, and the health-related business sales were described as providing $3.25 billion for shareholder returns and capital redeployment. The analysis also identified an estimated $2 billion gross California wildfire loss, partly offset by $900 million of reinsurance recoveries, with the net loss expected to be reflected in Q1 2025.
Guidance delta
The supplied analysis describes guidance sentiment as maintained; no specific numerical guidance was provided.
Key takeaways
- Management highlighted stronger Q4 results and improved underwriting, including property-liability and auto combined ratios of 86.9% and 93.5%.
- Growth plans center on affordable simple connected auto, homeowners products, protection plans, digitization, and broader distribution.
- The sales of the employer voluntary benefits and group health businesses are expected to provide $3.25 billion for shareholder returns and capital redeployment.
- California wildfire exposure, rate-driven retention pressure, competition, and investment-income volatility remain material risks.
Management priorities
- Continue rolling out affordable simple connected auto in additional states.
- Expand the homeowners product suite and pursue market-share growth.
- Use monthly policies-in-force disclosure to improve transparency.
- Complete the employer voluntary benefits and group health business sales in 2025 and use proceeds for capital redeployment.
Follow ALL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Underweight | Upgrade | Oct 12, 2026 |
| Keefe, Bruyette & Woods | Underperform | Underperform | Maintain | Oct 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Barclays | Underweight | Underweight | Maintain | Oct 7, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 6, 2026 |
| Citigroup | Sell | Sell | Maintain | Oct 2, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 1, 2026 |
| Argus Research | Hold | Buy | Downgrade | Aug 28, 2026 |
| BMO Capital | Buy | Buy | Maintain | Aug 13, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 11, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 10, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 10, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Aug 7, 2026 |
| Roth MKM | Buy | Buy | Maintain | Aug 6, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 6, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 6, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 6, 2026 |
| TD Cowen | Hold | Buy | Downgrade | Jan 12, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 18, 2025 |
| Roth Capital | Buy | Buy | Maintain | Nov 26, 2025 |
| Jefferies | Buy | Buy | Maintain | Aug 11, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 18, 2024 |
| CFRA | Hold | Buy | Downgrade | Oct 21, 2022 |
| MKM Partners | Buy | Buy | Maintain | Oct 20, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 28, 2022 |
| Wolfe Research | Perform | Peer Perform | Maintain | Aug 17, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | May 13, 2021 |
| Buckingham Research | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Compass Point | Buy | Buy | Maintain | Jan 15, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 7, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 7, 2018 |
| Argus | Buy | Buy | Maintain | May 9, 2018 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Apr 2, 2018 |
| Bank of America | Buy | Buy | Maintain | Feb 8, 2018 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 19, 2017 |
| Nomura | Neutral | Neutral | Maintain | Feb 4, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 15, 2015 |
| Sandler O'Neill | Buy | Hold | Upgrade | Sep 21, 2015 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Aug 4, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Oct 1, 2014 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Sep 27, 2012 |
| Drexel Hamilton | Hold | Hold | Maintain | Aug 1, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $247.88. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Elyse Greenspan | $236 | $229.43 | -4.8% | Oct 12, 2026 |
| Mizuho Securities | Analyst unavailable | $295 | $224.27 | +19.0% | Oct 7, 2026 |
| Barclays | Alex Scott | $221 | $224.27 | -10.8% | Oct 7, 2026 |
| HSBC | Analyst unavailable | $266 | $224.27 | +7.3% | Oct 7, 2026 |
| Goldman Sachs | Analyst unavailable | $250 | $221.86 | +0.9% | Oct 1, 2026 |
| Mizuho Securities | Analyst unavailable | $300 | $252.21 | +21.0% | Sep 18, 2026 |
| Mizuho Securities | Analyst unavailable | $297 | $257.21 | +19.8% | Sep 16, 2026 |
| Argus Research | Kevin Heal | $238 | $257.62 | -4.0% | Aug 28, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $267.77 | +6.9% | Aug 11, 2026 |
| Raymond James | Analyst unavailable | $315 | $266.31 | +27.1% | Aug 11, 2026 |
| UBS | Analyst unavailable | $275 | $271.07 | +10.9% | Aug 10, 2026 |
| Goldman Sachs | Robert Cox | $280 | $275.11 | +13.0% | Aug 7, 2026 |
| Wells Fargo | Analyst unavailable | $250 | $275.11 | +0.9% | Aug 7, 2026 |
| Roth Capital | Analyst unavailable | $300 | $264.59 | +21.0% | Aug 6, 2026 |
| Barclays | Alex Scott | $226 | $264.59 | -8.8% | Aug 6, 2026 |
| Roth Capital | Analyst unavailable | $275 | $248.55 | +10.9% | Jul 17, 2026 |
| Atlantic Equities | Analyst unavailable | $319 | $240.55 | +28.7% | Jul 15, 2026 |
| UBS | Analyst unavailable | $261 | $250.35 | +5.3% | Jul 15, 2026 |
| Evercore ISI | David Motemaden | $240 | $250.59 | -3.2% | Jul 10, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $242 | $249.27 | -2.4% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $272 | $251.17 | +9.7% | Jul 9, 2026 |
| Barclays | Alex Scott | $213 | $248.37 | -14.1% | Jul 7, 2026 |
| Raymond James | Analyst unavailable | $300 | $248.04 | +21.0% | Jul 6, 2026 |
| Morgan Stanley | Bob Huang | $240 | $250.33 | -3.2% | Jul 6, 2026 |
| HSBC | Vikram Gandhi | $264 | $250.33 | +6.5% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $268 | $217.26 | +8.1% | May 1, 2026 |
| Raymond James | Gregory Peters | $260 | $213.61 | +4.9% | Mar 3, 2026 |
| Mizuho Securities | Analyst unavailable | $281 | $207.55 | +13.4% | Feb 9, 2026 |
| Goldman Sachs | Analyst unavailable | $238 | $207.55 | -4.0% | Feb 7, 2026 |
| Wells Fargo | Elyse Greenspan | $228 | $212.13 | -8.0% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $255 | $197.65 | +2.9% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $223 | $208.66 | -10.0% | Jan 13, 2026 |
| Goldman Sachs | Analyst unavailable | $227 | $207.27 | -8.4% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $225 | $208.97 | -9.2% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $215 | $211.69 | -13.3% | Dec 16, 2025 |
| Mizuho Securities | Yaron Kinar | $254 | $211.69 | +2.5% | Dec 15, 2025 |
| Roth Capital | Harry Fong | $240 | $212.65 | -3.2% | Nov 26, 2025 |
| UBS | Analyst unavailable | $250 | $213.06 | +0.9% | Oct 8, 2025 |
| Evercore ISI | David Motemaden | $233 | $214.65 | -6.0% | Oct 1, 2025 |
| Roth Capital | Analyst unavailable | $230 | $209.82 | -7.2% | Sep 26, 2025 |
| Wells Fargo | Analyst unavailable | $202 | $205.55 | -18.5% | Aug 5, 2025 |
| Barclays | Alex Scott | $198 | $192.28 | -20.1% | Jul 31, 2025 |
| Wells Fargo | Elyse Greenspan | $197 | $200.17 | -20.5% | May 6, 2025 |
| Raymond James | Gregory Peters | $250 | $200.25 | +0.9% | May 5, 2025 |
| Wells Fargo | Elyse Greenspan | $187 | $186.04 | -24.6% | Jan 14, 2025 |
| BMO Capital | Michael Zaremski | $214 | $195.51 | -13.7% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $233 | $195.51 | -6.0% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $216 | $184.91 | -12.9% | Oct 10, 2024 |
| Raymond James | Gregory Peters | $220 | $187.84 | -11.2% | Oct 4, 2024 |
| Wells Fargo | Elyse Greenspan | $175 | $178.11 | -29.4% | Aug 16, 2024 |
| Piper Sandler | Paul Newsome | $196 | $178.11 | -20.9% | Aug 16, 2024 |
| CFRA | Catherine Seifert | $200 | $180.95 | -19.3% | Aug 14, 2024 |
| Wells Fargo | Elyse Greenspan | $177 | $171.03 | -28.6% | Aug 12, 2024 |
| Jefferies | Yaron Kinar | $217 | $169.02 | -12.5% | Aug 5, 2024 |
| BMO Capital | Michael Zaremski | $205 | $176.82 | -17.3% | Aug 5, 2024 |
| BMO Capital | Michael Zaremski | $191 | $176.69 | -22.9% | Jul 18, 2024 |
| Piper Sandler | Paul Newsome | $188 | $173.01 | -24.2% | Apr 1, 2024 |
| HSBC | Vikram Gandhi | $190 | $169.84 | -23.4% | Mar 28, 2024 |
| Wells Fargo | Analyst unavailable | $104 | $131.68 | -58.0% | Feb 3, 2023 |
| Evercore ISI | Analyst unavailable | $138 | $131.53 | -44.3% | Feb 2, 2023 |
| Piper Sandler | Analyst unavailable | $153 | $140.01 | -38.3% | Jan 10, 2023 |
| Goldman Sachs | Analyst unavailable | $166 | $140.36 | -33.0% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $137 | $134.26 | -44.7% | Nov 22, 2022 |
| Credit Suisse | Andrew Kligerman | $188 | $121.39 | -24.2% | Sep 2, 2022 |
| Morgan Stanley | Analyst unavailable | $140 | $131.18 | -43.5% | Aug 19, 2022 |
| Piper Sandler | Analyst unavailable | $147 | $141.13 | -40.7% | Apr 22, 2022 |
| Raymond James | Gregory Peters | $165 | $141.8 | -33.4% | Mar 27, 2022 |
| Raymond James | Gregory Peters | $145 | $125.88 | -41.5% | Mar 14, 2022 |
| Goldman Sachs | Alex Scott | $142 | $125.68 | -42.7% | Mar 3, 2022 |
| Jefferies | Yaron Kinar | $122 | $121.54 | -50.8% | Jan 6, 2022 |
| Barclays | Tracy Benguigui | $119 | $121.54 | -52.0% | Jan 6, 2022 |
| Deutsche Bank | Phil Stefano | $131 | $134 | -47.2% | May 13, 2021 |
| Argus Research | Kevin Heal | $155 | $131.05 | -37.5% | May 10, 2021 |
Track every rating change on ALL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Allstate Corporation, along with its affiliated entities, provides a comprehensive suite of property, casualty, and other insurance offerings throughout the United States and Canada. The company's operations are structured across four primary business segments: Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability. The Allstate Protection segment delivers a wide array of personal and commercial insurance solutions. This includes standard private passenger auto and homeowners policies, as well as specialized vehicle coverage for motorcycles, trailers, motor homes, and off-road vehicles. Additional personal lines encompass renter, condominium, landlord, boat, umbrella, manufactured home, and stand-alone scheduled personal property policies. Commercial lines products are also available, marketed under the Allstate and Encompass brand names. The Protection Services division focuses on consumer protection and related financial services.…
Historical context
All ALL earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | M&T Bank highlights deposits, CRE growth and AI efficiency in Q3 |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Regions Financial: Fee Growth and Technology Investment Lead Q3 Readout |
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | M&T: Loan and Deposit Growth Offset a Modest Q3 Earnings Decline |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Regions Financial Maintains Growth Outlook as Fee Revenue Sets Records |
| TFC-PI Truist Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Truist refocuses on relationship banking while investing for growth |
| TRV The Travelers Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +0.5% | Travelers posts strong Q3 underwriting results as AI investment continues |
Latest beats and misses
Who reports nextBeat on EPS
- IBKRFY2026 Q3 · October 15, 2026+0.3% EPS-3.9% move
- AAFY2026 Q3 · October 15, 2026+20.5% EPS+7.2% move
- JBHTFY2026 Q3 · October 15, 2026+0.6% EPS-2.0% move
- PLDFY2026 Q3 · October 15, 2026+105.9% EPS-2.7% move
- BNYFY2026 Q3 · October 15, 2026+4.4% EPS+3.2% move
- USB-PRFY2026 Q3 · October 15, 2026+1.5% EPS— move
Get the ALL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-22T00:04:22.296664+00:00
- Polygon adjusted daily market bars · 2026-10-17T02:30:43.300950+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T02:30:43.298117+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.